What share have you recently bought and why did you buy it?

-->

5th Jun '15 by WarrantStar

2 comments 8416 reads

I recently bought 32RED after my analysis, the summary of which is as follows:

MASSIVE GRAHAM FORMULA MARGIN OF SAFETY., GOOD MARGIN OF SAFETY RELATIVE TO SECTOR, HIGHEST STOCK RANK OF SIMILAR COMPANIES. SHARES MAG SAYS BUY. VERY HIGH ROCE. CHANGE TOWARDS MOBILE LOOKS A GOOD MOVE, VERY STRONG TRADING UPDATE.

So what have you recently bought? And Why did you buy it?

Unlock with Email

Unlock with Google

Already have an account?
Login here

About the Author

WarrantStar

Premium Member

I am a keen & experienced investor. I love my spread sheets, and like to think that I know what I am doing. I wouldn't be offended to be described as a bit geeky. Mostly I do well, but I always strive to do better. Married male. Born 1957 England. Good career in industry for 35 years. Been successfully investing for about 30 years. I chose to retire from salaried employment at age 57 to look after my investments. I consider myself to be quite analytical / logical / mathematical, but also take into account how the world is likely to change & how people behave. I always follow my processes before taking action. more »

2 comments

Rusty2

6th Jun '15

I bought Novae today, its a Lloyds Insurance syndicate. It scores 100 on VM on SR. Graham Formula is 291% so it looks good value. Several Lloyds syndicates have been taken over recently like Catlin. Dividend is 4.1%
? over EPS. OK profits are unpredicable with this type of insurance company. Thats about it.

iwright7

20th Jul '15

Just brought a few more 32Red (LON:TTR) ahead of Thursday interim. My purchase notes:

Growth company. Low PER of 10 with 0.31 PEG, F Score 8 (almost 9) with excellent return numbers, Q 99 and SR 96, Passes Can Slim, Zulu and Bold Revisions screens (2016 Est +27%), Strong 2015 March trading update when YTD sales up +35%. Organic 5Y top line sales growth with heavy targeted TV advertising, 33% and growing mobile revenue, high 4% spread, New Roxy acquisition increases T/O by 33% and is earnings enhancing with a big opportunity for cost rationalisation. Can- Slim +25% re-rate opportunity. Good hunting Ian

Unlock the metrics for all these stocks and more...

Take a free trial

Facebook Twitter Youtube Instagram RSS

This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.

Unlock the metrics for all these stocks and more...

Take a free trial

What share have you recently bought and why did you buy it?

Unlock the rest of this article with a 14 day trial

About the Author

WarrantStar

2 comments

Unlock the metrics for all these stocks and more...

Unlock the metrics for all these stocks and more...